• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    High Drug Loading Amorphous Solid Dispersions

    Parenteral Drug Delivery Trends

    Selecting the Right Outsourcing Model for Emerging Biotech

    Inhaled Drug Delivery Technology

    The Future of Biologics: Accelerating Production, Reducing Costs
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Spark Therapeutics Appoints CTO

    Cryoport Launches ESG Program

    U.S. Govt. Purchases 100k Doses of Lilly's COVID-19 Antibody Cocktail

    Thermo Fisher Scientific Completes Mesa Biotech Acquisition

    Ashfield Engage, Popit Form Digital Monitoring Collaboration
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Solid Dose Market Trends

    CatSci Opens New Site in UK

    Pfizer Partners with Medicines Manufacturing Innovation Center

    C2 Pharma Completes Multiple Regulatory Filings

    Bormioli Opens New Glass Research Center
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Covectra Introduces Next-Gen Serialization Solution

    Bormioli Opens New Glass Research Center

    Centrient Pharmaceuticals to Acquire Astral SteriTech

    Seasonal Vaccine Manufacturing

    PwC Joins Medicines Manufacturing Innovation Centre
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Ashfield Engage, Popit Form Digital Monitoring Collaboration

    AMRI Contributes to Efforts to Increase COVID-19 Vax Supply

    CatSci Opens New Site in UK

    Pfizer Partners with Medicines Manufacturing Innovation Center

    CrownBio & JSR Life Sciences Partner with Cambridge Quantum Computing
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    test company saurabh

    Aphena Pharma Solutions

    Baxter BioPharma Solutions

    Alcami

    Emergent BioSolutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    PCI Pharma Services

    Syngene

    test company saurabh

    Aphena Pharma Solutions

    Baxter BioPharma Solutions
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    Contract Manufacturing in the Supplement Industry

    With consumer health products in demand, manufacturing specialists offer considerable value.

    Contract Manufacturing in the Supplement Industry
    Related CONTENT
    • Vetter continues its successful performance at the 2021 CMO Leadership Awards
    • Embedding Your Drug Strategy Within a Solid Foundation for Success
    • Pfizer, BioNTech To Supply 200M More Vax Doses to EU
    • Argonaut Opens Custom Controls and Standards Facility
    • Novartis Inks Contract Manufacturing Deal for Pfizer-BioNTech COVID-19 Vaccine
    Sean Moloughney, Editor, Nutraceuticals World03.07.17
    Demand for wellness products continues to gain steam, fueled by an aging population with a preference for natural, holistic medicine and also a younger, emerging demographic that has adopted a general self-care and preventive approach to health. 

    Globally, sales of consumer health products reached $219 billion in 2016, up 3%, according to Euromonitor International. Sales are projected to top $250 billion with ongoing growth of 3% per year through 2021. Meanwhile, dietary supplement sales are projected to reach $127.9 billion globally in 2017, up 6.1%, according to Nutrition Business Journal. Weight management, herbal/combination/traditional supplements and sports nutrition are expected to post the fastest growth through 2021, per Euromonitor.

    In terms of the health issues consumers care about, maintaining mental sharpness with age was the number one health concern globally in 2016, according to HealthFocus International. Other health concerns included ability to continue normal activity with age (45%), oral health (43%), tiredness/lack of energy (43%), back/neck pain (41%), stress (40%), eye health (39%), lack of mental focus (36%),and skin appearance (27%).  

    As the dietary supplement industry has grown, regulatory oversight has increased. FDA’s creation of the Office of Dietary Supplement Programs in late 2015 underscores this added regulatory attention. Additionally, FDA’s new dietary ingredient notification (NDIN) draft guidance continues to get significant attention. How exactly it will be implemented and enforced remains to be seen under the new presidential administration.

    Overall, in today’s environment, supply chain integrity and adherence to current Good Manufacturing Practice (cGMP) requirements are critical to quality, and ultimately the health of supplement brands.

    More than Manufacturers
    Against this backdrop, contract manufacturing has become more valuable. In the evolution of the dietary supplement industry, contract manufacturers have become full-time partners for brand marketers, offering not just an assembly line, but also an analytical laboratory, a research facility, and regulatory assistance, said Mark Potocnjak, CFO, Herbally Yours, Gilbert, AZ.

    “The fiduciary role of contract manufacturer is growing and it is becoming more and more prominent with industry growth,” he said. “We have a well established network of partners, from lawyers and regulatory experts to laboratories and suppliers, to assist brands beyond production of the bottle. The role of the manufacturer should not end when the product leaves the facility, but it is extended during and beyond the expiration date.”

    Contract manufacturers can help companies develop products from infancy, through research, development and formulation, to a complete market-ready item, Mr. Potocnjak added. “Partnering with the right contract manufacturer eliminates the need to compile several different companies who work on formulation, sourcing the right ingredients, testing, development, etc., into one roof, allowing the marketer to focus on marketing and sales.”

    At times, dispersing those services can lead to confusion, which can be costly during new product development, he noted. “Consolidating those services at the hands of a trustworthy contract manufacturer will allow brands more time and resources to focus on what they do best.”

    The cost of operating a cGMP compliant manufacturing facility is substantial, taking resources away from market research, clinical trials, distribution, marketing, etc.

    Jennifer Cusick, director of sales operations, Trividia Manufacturing Solutions, Inc., Lancaster, NH, said contract manufacturing organizations (CMOs) play a key role in the industry, specifically with the regulatory aspects of manufacturing to the appropriate cGMPs regulations.

    “It is imperative for the CMO to thoroughly understand the brand labeling, to establish the internal quality systems specific to the appropriate regulatory class. Do the ingredients and label claims require adherence to food, dietary supplement, medical food or another set of cGMP regulations?”

    The role of CMOs has evolved along with the broader industry, she added. “As CMOs have a responsibility to manufacture within full compliance, and some brand owners are reluctant to pay for the added costs as regulations increase, the role of the CMO focuses on educating the smaller clients, or those new to the industry. For CMOs that manufacture products that fall under a variety of regulatory classes, the increased costs of compliance require the CMO to establish Master Formula Records and quality processes that are specific to each regulatory class.”

    For a new brand owner, partnering with a CMO can provide a range of benefits, from formulation services, education, sourcing expertise, and regulatory compliance knowledge. “The expertise in manufacturing can provide efficiencies and costs savings while the brand owner can focus on sales and marketing. The value of the CMO is their area of expertise,” said Ms. Cusick.

    John Altenberg, vice president of sales, Vit-Best Nutrition, Tustin, CA, offered two broad reasons for choosing a contract manufacturer. First, CMOs offer value in managing the supply chain, which allows company to focus on initiatives that build brand equity.

    “The other primary reason is to either outsource internal production as a means of cost savings or the dedication of limited capital and equipment to other brands,” he said. “Overlooked areas where CMOs can provide value include expertise in manufacturing certain ingredients and modalities, or certification(s) to sell products overseas. Whatever scenario drives the brand to outsource to a CMO must be built on transparency and trust.”

    Anthony Broom, sales manager, 4Excelsior, Anaheim, CA, said contract manufacturing helps brands develop superior formulations. “Contract manufacturers also have a lot of experience in sourcing, formulation development, and quality manufacturing processes, allowing supplement brands to focus on marketing the product to the client. Contract manufacturing benefits the client by making their lives easier, and helping them provide consumers with the best product possible.”

    In the past, CMOs provided basic functions around procurement of ingredients and manufacturing of products, according to Ephi Eyal, president & CEO of IFP, Inc., Faribault, MN. “The contemporary definition resembles a partnership and is driven by transparency, accountability and innovation.”

    A quality manufacturer provides the transparency and accountability associated with new standards in the industry, he added. “Most importantly, they must have world-class quality management and a solid infrastructure to implement the current standards efficiently and effectively to get products out to market quickly and cost-effectively. At IFP, we sell trust and product quality, and we take this seriously. We have made a large investment in our quality management systems, and we see this as a space that differentiates us, and offers our customers a competitive edge. Proven and well-run quality systems can ensure a quick and timely product launch rather than bog down a manufacturing process.”

    IFP sees itself as a trusted resource and innovation partner. “We offer knowledge on patented ingredients, powder processing, and particle engineering, retail packaging innovations or regulatory issues,” said Mr. Eyal. “Not only is IFP required to be an audited GMP-certified manufacturing firm that offers state of the art facilities, quality infrastructure, and ensured compliance, but it is necessary for us to have a finger on the pulse of all that is new in the industry and marketplace to offer clients meaningful conversations to innovate quickly.”

    More companies are partnering with CMOs so they can focus on marketing, he added. “They trust the required diligence associated with quality and manufacturing standards to their CMO partners. We see our clients stay with us not only because of our commitment to quality standards but also because of our evolving processes that help get products to the shelf faster and cost effectively.”

    Reviewing Qualifications
    There are a few items companies should pay attention to when selecting and qualifying contract manufacturer, noted Mr. Potocnjak. “Reputation and certification is definitely a primary one. Always look for certifications and ask to confirm them,” he said. “Logos on a website mean nothing without a current certificate from an issuing agency.”

    Transparency is another vital issue, as contract manufacturers are last in the supply chain to actually see and touch the product before it reaches the consumer. Mr. Potocnjak called this a “huge fiduciary responsibility.”

    “Always look for a manufacturer that is comfortable sharing information, laboratory data, and will always have their doors open for inspection or tour,” he offered.

    Brands should also look for a manufacturer that has experience and capabilities to produce their products. “One of the questions that I have been asked frequently, and still confuses me the most, is ‘what is the size of the facility?’ It is an irrelevant number and without a physical tour of the manufacturing plant—from laboratory and regulatory department to packaging line—will provide no relevant information.”

    Ms. Cusick also recommended companies qualify CMOs by “visiting their facility, understanding their culture, reviewing their compliance issues and reviewing their audit documentation.”

    A quality CMO offers consumer insights, product development, manufacturing, and product support, according to Mr. Eyal, but also has the flexibility to offer specific technologies and services as needed.

    Additionally, CMOs must provide transparency and accountability associated with new standards in the industry. “Most importantly, they must have world-class quality management and a solid infrastructure to implement the current standards efficiently and effectively to get products out to market quickly and cost-effectively,” he said.

    CMOs should also provide innovative, value-driven ideas to present to customers. “We see ourselves as a trusted resource, whether it is offering knowledge on patented ingredients, packaging innovations or regulatory issues, we create new and better. The services demanded require the CMO to maintain an expensive overhead structure to support R&D, regulatory, engineering, and manufacturing activities while playing in a competitive market space in which cost is an important driver.”

    Mr. Altenberg said transparency leads to trust and evaluations of potential CMO partners should include: R&D experience with ingredients in formulas; firm control of production process with detailed documentation;  equipment and operators that can handle challenging material; example of QA programs and their success stories; how does the CMO handle interruptions to the supply chain; how versed is management in daily details of business?

    Mr. Broom said 4Excelsior prides itself on third party certifications. “This helps provide clients with confidence that the manufacturer can provide them with a quality service that has been third party validated.”

    One of the biggest challenges for contract manufacturers is competing at certain price points, he added. “There are those in the market that will take shortcuts to meet a brand’s price point. It does become difficult when trying to compete with those groups in the industry.”

    Ms. Cusick said escalating testing costs and the redundancy of auditing present challenges as well. “As a CMO that has maintained many third party certifications (such as NSF and UL) for sports nutrition, dietary supplements, OTCs and Canadian drugs and natural health products, we are still subject to many, many customer audits. Although UL markets the universal acceptance of its certifications, we routinely find the retailers do not accept the certification at face value, and require additional audits. The requirements for social audits is also increasing. If the industry could consolidate auditing standards and get the buy-in and support of the largest retailers, the industry could gain efficiencies. The focus could be moved from supporting the redundant audits to focusing on improving compliance.”

    Product Trends
    Mr. Broom, noted that 4Excelsior, a full-service contract manufacturer that offers powder blending, encapsulation and tableting, has seen strong growth for organic greens, and vegan protein sources. “There’s been a strong move from the industry toward sourcing organic materials and targeting the vegan/organics market. Our specialty has really been in flavor development within the industry; we managed to develop some great tasting formulas for both the sports nutrition and naturals sector.”

    Demand for organic materials and “clean label” products has been driven by consumers who are more aware of what they are putting into their bodies.

    “We certainly see it becoming essential that manufacturers offer services for the non-GMO, organics sector. We only see brands wanting to offer more transparency to their consumers.”

    In that move to go more natural, the use of traditional excipients has been questioned. “Brands want to push toward a more natural approach when it comes to encapsulation projects,” said Mr. Broom.

    As for product and dosage format, Ms. Cusick said Trividia has offered tablet formulation services for many years. “In recent years we have done a lot more liquids/lotions/creams formulations. We are noticing that brand owners are more focused on natural materials with some specific interest in natural preservatives.

    Lisa Unlu, senior food scientist at IFP, said clean label foods can mean different things to consumers. “For some, it means shifting from GM ingredients to non-GMO ingredients. For others, it’s a shift all the way to organic. Clean label also means shorter ingredient declarations, so the importance of every ingredient for function and purpose is critical.”

    Transparency is also important from a labeling perspective, she said. “Being very clear about exactly what is in the food, using common words to describe food ingredients, is known as ‘clear labeling,’ or labeling transparency. Additionally, this includes labeling GM ingredients when they are in foods. Essentially, consumers are looking for more information about what is put into their food, to make more informed decisions about their food choices.”

    In terms of ingredients, protein is definitely trending, she added. “Many of the new products being developed contain one or more of the ‘in demand’ proteins—from pea protein, hemp, lentil, fava bean protein, to the tried and true dairy proteins like whey protein isolate, whey protein concentrate or casein. One shift seen more recently from our customers is to have sources of dairy from grass-fed cows and organic farms. The same could be said for the vegetable proteins; the requests are more commonplace to have organic sources versus traditional sources of supply.”

    Ms. Unlu also noted demand for fruits/vegetables, greens, probiotics, antioxidant sources, digestive enzymes and sugar reduction.
    Ultimately, Mr. Altenberg said customers continue to research and develop formulas for “lifestyle solutions.”

    The Evolution Continues
    In the future, Mr. Potocnjak predicted contract manufacturers will become more transparent, allowing for a better flow of information. “As the industry matures, the market is becoming increasingly saturated with existing formulations, private labeled products, and development of new formulas. The introduction of new dietary ingredients will be an exciting challenge for contract manufacturing—from a manufacturing and a regulatory stance.”

    Additionally, Mr. Potocnjak noted a common misunderstanding about the different services provided by contract manufacturers versus private label manufacturers.

    “I hope in the future we will see more clear separation of those two different services, and better understanding of their difference. While private label services offer excellent products, at lower cost, without the need to develop new formulations, it is a very different operation than contract manufacturing. I like to look at contract manufacturers as research facilities with a large assembly line under the same roof.”

    Ms. Cusick said she believes CMOs need to continue to focus on regulatory compliance. Those that do not will eventually meet their own demise. “Brand owners who grew manufacturing as their brands grew, but their area of focus was sales and marketing, are now outsourcing their manufacturing. Rather than invest in their facilities, both structural and process/compliance needs, they are evaluating and outsourcing products.”

    Form a third-party perspective, she added, “we find that some (large) brand owners are not as ‘tight’ with regulatory compliance as we are, as we have a focus strictly on manufacturing. Another observation is regarding brand sales. As brands are sold to venture capital firms or virtual companies, the manufacturing is moving from the brand owner facility to a contract manufacturer. We also notice foreign companies that acquire brands manufactured and sold in the U.S. are looking for U.S. CMOs to continue the manufacturing.” Additionally, international brands looking to expand into the U.S. market are partnering with U.S.-based manufacturers.

    Contract manufacturing has always been an important vehicle for the industry, according to Mr. Altenberg. “The entrepreneurial nature of the industry has often emerged from those with a product idea and marketing message. Outsourcing their production has and will continue to be of importance to minimize capital outlays and allow professionals to ensure quality.” 
    Related Searches
    • medical food
    • GMP
    • sourcing
    • Dosage
    Suggested For You
    Vetter continues its successful performance at the 2021 CMO Leadership Awards Vetter continues its successful performance at the 2021 CMO Leadership Awards
    Embedding Your Drug Strategy Within a Solid Foundation for Success Embedding Your Drug Strategy Within a Solid Foundation for Success
    Pfizer, BioNTech To Supply 200M More Vax Doses to EU Pfizer, BioNTech To Supply 200M More Vax Doses to EU
    Argonaut Opens Custom Controls and Standards Facility Argonaut Opens Custom Controls and Standards Facility
    Novartis Inks Contract Manufacturing Deal for Pfizer-BioNTech COVID-19 Vaccine Novartis Inks Contract Manufacturing Deal for Pfizer-BioNTech COVID-19 Vaccine
    Thermo Fisher Buys Novasep Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz
    LSNE Expands Fill Finish and Lyophilization Ops LSNE Expands Fill Finish and Lyophilization Ops
    Baxter, Novavax Ink Sterile Manufacturing Agreement Baxter, Novavax Ink Sterile Manufacturing Agreement
    Fujifilm to Invest $40M in New Facility Fujifilm to Invest $40M in New Facility
    Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management
    Sesen Bio Enters Mfg. and Supply Partnership with Qilu Pharma Sesen Bio Enters Mfg. and Supply Partnership with Qilu Pharma
    Asymchem Asymchem
    Life Science Success Podcast: Matt Hicks Life Science Success Podcast: Matt Hicks
    Baxter Invests $50M to Expand Sterile Fill/Finish Manufacturing Operations Baxter Invests $50M to Expand Sterile Fill/Finish Manufacturing Operations
    A Potential “Marriage” A Potential “Marriage”

    Related Features

    • Solid Dosage/Creams/Ointments
      High Drug Loading Amorphous Solid Dispersions

      High Drug Loading Amorphous Solid Dispersions

      A Novel Tablet Architecture for Amorphous Solid Dispersions to Achieve High Drug Loadings
      Deanna Mudie and Aaron Stewart, Lonza 01.27.21

    • Parenterals
      Parenteral Drug Delivery Trends

      Parenteral Drug Delivery Trends

      A Q&A with Lubrizol Life Science Health’s CDMO Division President, Rob Lee.
      Kristin Brooks, Managing Editor, Contract Pharma 01.27.21

    • Selecting the Right Outsourcing Model for Emerging Biotech

      Selecting the Right Outsourcing Model for Emerging Biotech

      Flexible outsourcing models help drive quality, control costs and enable better efficiencies and faster delivery.
      Timothy King and Elisha Talley-Roithner, PPD 01.27.21


    • Drug Delivery
      Inhaled Drug Delivery Technology

      Inhaled Drug Delivery Technology

      The success of any new inhaled medicine relies in a large part on the correct combination of formulation and device technology being chosen for its delivery.
      Dr. Sandy Munro, Vice President – Pharmaceutical Development, Vectura 01.27.21

    • Biologics, Proteins, Vaccines
      The Future of Biologics: Accelerating Production, Reducing Costs

      The Future of Biologics: Accelerating Production, Reducing Costs

      Yeast-based gene expression offers pharma the yield and efficiencies it needs to make pandemic-stopping vaccines faster and more economical.
      Mark Emalfarb, Dyadic 01.27.21

    • Analytical Services | Information Technology | Laboratory Testing
      Business Intelligence For (and From) the Lab

      Business Intelligence For (and From) the Lab

      How a digital ecosystem can harness the most data-rich environment in the CDMO.
      Bob Voelkner, VP Sales and Marketing, LabVantage 01.27.21


    • Communicating Your Contracting Priorities to Your Drug Company Customers

      Communicating Your Contracting Priorities to Your Drug Company Customers

      A discussion with Perrigo’s senior legal counsel, Susan Fyan, about issues that arise in very fact-specific contract negotiations between CDMOs and sponsors.
      Stephen Sayre, Dykema 01.27.21

    • COVID-19 Impact Report

      COVID-19 Impact Report

      Leaders across the pharmaceutical contract services industry reflect on the impact of COVID-19 in 2020, and what to expect in 2021.
      Tim Wright, Editor, Contract Pharma 01.27.21

    • Biologics, Proteins, Vaccines | Regulatory Affairs
      The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

      The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

      A look at EUA standards and approvals, unavoidable pitfalls, Operation Warp Speed, FDA’s use of Real-World Evidence, and a slow return to “normalcy.”
      Chad Landmon, Michelle Divelbiss and Alex Alfano, Attorneys - Axinn, Veltrop & Harkrider LLP 01.27.21


    • Excipients
      Bye-Bye China?

      Bye-Bye China?

      Instead of closing its doors on China, Western pharma industry needs to take a balanced approach and perform proper due diligence based on objective criteria.
      Michele Jermini and Enrico Polastro 11.17.20

    • Clinical Trials | Information Technology | R&D
      Decentralized Trials Fuel AI Revolution in Clinical Research

      Decentralized Trials Fuel AI Revolution in Clinical Research

      The life sciences industry is giving clinical a full makeover, dramatically improving how new therapeutics are developed.
      Nick Moss, Vice President of Analytics and Machine Learning, Medable 11.17.20

    • Drug Delivery | Injectables
      Self-Medication: Flexibility for Patients and Drug Manufacturers

      Self-Medication: Flexibility for Patients and Drug Manufacturers

      Bringing together self-medication with auto-injectors and sustainable secondary packaging.
      Matthias Heinrichs, Head of Product Management and Project Engineering, Syntegon Technology 11.17.20


    • The Single-Use Mixing Landscape: Evaluating Your Options

      The Single-Use Mixing Landscape: Evaluating Your Options

      Adoption of single-use technologies has increased markedly in recent years and will continue to grow.
      Mark A. Sitcoske, Founder & CEO, High Purity New England 11.17.20

    • DCAT President Talks COVID-19, Drug Manufacturing and Innovation

      DCAT President Talks COVID-19, Drug Manufacturing and Innovation

      Lonza’s Director of Commercial Development, Sean Diver, was recently named President of DCAT.
      Tim Wright, Editor, Contract Pharma 11.17.20

    • Biologics, Proteins, Vaccines | Biosimilars | Drug Development
      Biopharma Contract Manufacturing: Robust Growth Ahead

      Biopharma Contract Manufacturing: Robust Growth Ahead

      The biopharmaceutical contract manufacturing market is projected to reach $6.3 billion in 2020, and it will continue to grow over the next five years.
      William Downey, HighTech Business Decisions 11.17.20

    Trending
    • Catalent Acquires Delphi Genetics
    • Inside A Vaccine Trial
    • Pfizer Selects Seven Bridges To Support RNA Sequencing Data
    • Pfizer Partners With Medicines Manufacturing Innovation Center
    • ICON Acquires Medpass
    Breaking News
    • Spark Therapeutics Appoints CTO
    • Cryoport Launches ESG Program
    • U.S. Govt. Purchases 100k Doses of Lilly's COVID-19 Antibody Cocktail
    • Thermo Fisher Scientific Completes Mesa Biotech Acquisition
    • Ashfield Engage, Popit Form Digital Monitoring Collaboration
    View Breaking News >
    CURRENT ISSUE

    January/February 2021

    • High Drug Loading Amorphous Solid Dispersions
    • Parenteral Drug Delivery Trends
    • Selecting the Right Outsourcing Model for Emerging Biotech
    • Inhaled Drug Delivery Technology
    • The Future of Biologics: Accelerating Production, Reducing Costs
    • Business Intelligence For (and From) the Lab
    • Communicating Your Contracting Priorities to Your Drug Company Customers
    • COVID-19 Impact Report
    • The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Refined Grains Linked to Heart Attack Risk, Early Death
    Kappa Bioscience Extends Research Partnership For COVID-19 Research
    New FDA Traceability Rule Appears to Omit Dietary Supplement Manufacturers
    Coatings World

    Latest Breaking News From Coatings World

    Nippon Paint Marine Wins Korea Export Award
    Universal Display Corporation, PPG Expand Global Production of UniversalPHOLED Materials
    PPG Introduces Premium Iso-free Primer Surfacer, Catalyst
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    January AI Raises $8.8 Million in New Funding
    FDA Clears Ava Fertility Tracking Wearable Device
    First Patient in Europe Treated With Diamondback 360 Coronary Orbital Atherectomy System
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Spark Therapeutics Appoints CTO
    Cryoport Launches ESG Program
    U.S. Govt. Purchases 100k Doses of Lilly's COVID-19 Antibody Cocktail
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    The Top Beauty Products of 2021, According to HelloGiggles
    Estée Lauder Taps Ana de Armas as Global Brand Ambassador
    Sephora Announces Significant Expansion
    Happi

    Latest Breaking News From Happi

    ACI Urges Senate to Approve Regan as EPA Administrator
    Estée Lauder Signs Actress Ana de Armas
    GUM Recalls Oral Spray
    Ink World

    Latest Breaking News From Ink World

    Etiflex Enters New Markets with Nilpeter FA-22 Installation
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Marshall & Bruce Adds Koenig & Bauer Rapida 106 41-Inch Seven-Color Press
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    FTA converts Forum & INFOFLEX to virtual events
    Xeikon launches two new digital label printing presses
    UFlex adds capacity in packaging films
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Texas Medical Technology Partners with My Protect Kit
    Mexico City Single-Use Plastics Ban Leads to Tampon Shortage
    Believe Diapers Launch in U.S.
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Fusion Robotics Receives FDA Clearance for Spinal Navigation and Robotics System
    Kaia Health Unveils Next-Gen Complete MSK Care Solutions
    First Implantation of CTL Amedica's Minimally Invasive Flex Tower
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login